MARSHALL WACE, LLP – Cytokinetics, Incorporated Transaction History
MARSHALL WACE, LLP portfolio value:
$46.31M
portfolio value
MARSHALL WACE, LLP quarter portfolio value change:
+23.31%
quarter
Cytokinetics, Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -29.36% | -397.25K shares | -6.85M | $48.45 | 955.88K |
| Q2 2022 | share | Increase | +4278.38% | 1.32M shares | 52.02M | $39.29 | 1.35M |
| Q1 2022 | share | Decrease | -30.03% | -13.26K shares | -876K | $36.81 | 30.90K |
| Q4 2021 | share | Increase | 0.00% | 44.17K shares | 2.01M | $45.6 | 44.17K |
| Q3 2021 | share | Decrease | -100.00% | -132.49K shares | -2.62M | $35.74 | 0 |
| Q2 2021 | share | Decrease | -51.63% | -141.40K shares | -3.74M | $19.79 | 132.49K |
| Q1 2021 | share | Increase | +423.94% | 221.62K shares | 5.28M | $23.26 | 273.90K |
| Q4 2020 | share | Decrease | -74.80% | -155.17K shares | -3.40M | $20.78 | 52.27K |
| Q3 2020 | share | Increase | 0.00% | 207.45K shares | 4.49M | $21.65 | 207.45K |
| Q2 2019 | share | Decrease | -100.00% | -7.99K shares | -65K | $11.25 | 0 |
| Q1 2019 | share | 0.00% | 0 shares | 14K | $8.09 | 7.99K | |
| Q4 2018 | share | Increase | 0.00% | 7.99K shares | 51K | $6.32 | 7.99K |
| Q2 2018 | share | Decrease | -100.00% | -30.6K shares | -220K | $8.3 | 0 |
| Q1 2018 | share | Increase | 0.00% | 30.6K shares | 220K | $7.2 | 30.6K |